2m 2m 2m 2m 2m 2m 2m
Oramed (ORMP)
NASDAQ
$4.66-$0.005 (-0.11%)
Price as of Sep 11, 2026 7:30 PM EDT- $193.8MMarket Cap
- 107.41%1-Year Change
- BiotechnologyIndustry
Oramed (ORMP)
$4.66-$0.005 (-0.11%)
ORMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.66 | ||
Change | -$0.10 (-2.10%) | ||
Open | $4.81 | ||
High | $4.82 | ||
Low | $4.65 | ||
Previous Close | $4.76 | ||
Volume | 144,534 | ||
30-Day Average Volume | 225,944 | ||
1-Week Change | -6.99% | ||
1-Month Change | 9.65% | ||
1-Year Change | 107.41% | ||
3-Year Change | 64.43% | ||
5-Year Change | -74.38% | ||
Fundamentals | |||
Shares Outstanding | 41.6M | ||
Total Assets | $369.6M | ||
Market Cap | $193.8M | ||
Enterprise Value | $203.6M | ||
Period: QTR TTM FY | |||
Revenue | $97.0M | ||
Net Income | $78.2M | ||
Free Cash Flow | -$202,000.00 | ||
EBIT | $101.6M | ||
EBITDA | $101.6M | ||
Net Working Capital | $42.7M | ||
EPS | $1.84 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | 3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -960 | ||
Price/Operating Cash Flow | -969 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 48.28% | ||
Trailing Annual Dividend Yield | 5.36% | ||
Ex-Dividend Date | 01/16/2026 | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/23/2013 | ||
Earnings & Revenue
Annual Dividend Yield